TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 4:02 · GLP-1 & Metabolic Drugs · RBI leaders see negligible impact from GLP-1 drugs on restaurant industry
episode briefing
In Good Company with Nicolai Tangen

Chair and CEO of Restaurant Brands International (RBI) | In Good Company | Podcast

2024-03-20 · 1 company · 3 thematic
sentiment
1 bull0 bear0 neu
speakers
patrick doyle

Patrick Doyle is Executive Chair of RBI (Burger King, Tim Hortons, Popeyes, Firehouse Subs) and former CEO of Domino's Pizza, where he led a major turnaround.

now playing · GLP-1 & Metabolic Drugs
Franchise Business Modelstailwindscore 8/10patrick doyle
Franchisee cash-on-cash returns are the single metric that determines QSR franchisor success
The health of a franchise system depends entirely on franchisee returns; when franchisees earn great cash-on-cash returns, they reinvest and accelerate brand growth, which flows through to…
GLP-1 & Metabolic Drugstailwindscore 7/10patrick doyle
RBI leaders see negligible impact from GLP-1 drugs on restaurant industry
Even if 10-20% of people adopt GLP-1 drugs and reduce calories 10-20%, the net effect is only 1-4% calorie reduction industry-wide; employment levels are the true driver of restaurant deman…
Demographicstailwindscore 6/10josh kobza
Canada immigration-driven population growth fuels Tim Hortons domestic expansion
Canada's 1.5% annual population growth from immigration creates structural demand for new Tim Hortons locations, supporting at least 1.5% annual unit growth in the brand's largest profit co…